Cargando…

Hypertension after preeclampsia and relation to the C1114G polymorphism (rs4606) in RGS2: data from the Norwegian HUNT2 study

BACKGROUND: Preeclampsia is associated with an increased risk of hypertension later in life. The regulator of G protein signaling 2 negatively regulates several vasoconstrictors. We recently demonstrated an association between preeclampsia and the CG or GG genotype of the C1114G polymorphism (rs4606...

Descripción completa

Detalles Bibliográficos
Autores principales: Kvehaugen, Anne Stine, Melien, Øyvind, Holmen, Oddgeir L, Laivuori, Hannele, Dechend, Ralf, Staff, Anne Cathrine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973870/
https://www.ncbi.nlm.nih.gov/pubmed/24593135
http://dx.doi.org/10.1186/1471-2350-15-28
_version_ 1782479384090771456
author Kvehaugen, Anne Stine
Melien, Øyvind
Holmen, Oddgeir L
Laivuori, Hannele
Dechend, Ralf
Staff, Anne Cathrine
author_facet Kvehaugen, Anne Stine
Melien, Øyvind
Holmen, Oddgeir L
Laivuori, Hannele
Dechend, Ralf
Staff, Anne Cathrine
author_sort Kvehaugen, Anne Stine
collection PubMed
description BACKGROUND: Preeclampsia is associated with an increased risk of hypertension later in life. The regulator of G protein signaling 2 negatively regulates several vasoconstrictors. We recently demonstrated an association between preeclampsia and the CG or GG genotype of the C1114G polymorphism (rs4606) of the regulator of G protein signaling 2 gene. Here, we examined the polymorphism with respect to the development of hypertension after pregnancy. METHODS: We genotyped 934 women on average 15.1 years after preeclampsia and 2011 age matched women with previous normotensive pregnancy. All women in this study were retrospectively recruited from the Nord-Trøndelag Health Study (HUNT2). Information from HUNT2 was linked to the Medical Birth Registry of Norway to identify women with a history of preeclampsia and women without a history of preeclampsia. RESULTS: No significant association was found between hypertension (blood pressure ≥140/90 mmHg and/or taking antihypertensive drugs) and the polymorphism in crude analysis (OR (95% CI): CG genotype: 1.07 (0.90-1.27); GG genotype: 1.23 (0.90-1.67)). However, in a minimally adjusted model (age and BMI adjusted), a significant association between the GG genotype and hypertension was found (OR (95% CI): 1.49 (1.05-2.11)). This association remained significant also after adjustment for a history of preeclampsia (OR (95% CI): 1.46 (1.02-2.09)), but not in a model adjusted for multiple other variables (OR (95% CI): 1.26 (0.82-1.94)). In multivariate, but not in crude, analysis, the GG genotype of rs4606 (OR (95% CI): 1.93 (1.05-3.53)) was significantly and independently associated with severe hypertension later in life, defined as systolic blood pressure ≥160 mmHg (stage 2 hypertension) and/or taking antihypertensive drugs. A significant association was also found for the merged CG and GG genotypes (OR (95% CI): 1.43 (1.02-2.00)). Moreover, an interaction with physical activity was found. A history of preeclampsia was a significant and independent predictor of either definition of hypertension, both in crude and adjusted analyses. CONCLUSION: Women carrying the rs4606 CG or GG genotype are at elevated risk for developing hypertension after delivery. Physical activity may interact with the association. Preeclampsia remains an independent risk factor for subsequent hypertension after adjusting for this polymorphism and classical CVD risk factors.
format Online
Article
Text
id pubmed-3973870
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39738702014-04-04 Hypertension after preeclampsia and relation to the C1114G polymorphism (rs4606) in RGS2: data from the Norwegian HUNT2 study Kvehaugen, Anne Stine Melien, Øyvind Holmen, Oddgeir L Laivuori, Hannele Dechend, Ralf Staff, Anne Cathrine BMC Med Genet Research Article BACKGROUND: Preeclampsia is associated with an increased risk of hypertension later in life. The regulator of G protein signaling 2 negatively regulates several vasoconstrictors. We recently demonstrated an association between preeclampsia and the CG or GG genotype of the C1114G polymorphism (rs4606) of the regulator of G protein signaling 2 gene. Here, we examined the polymorphism with respect to the development of hypertension after pregnancy. METHODS: We genotyped 934 women on average 15.1 years after preeclampsia and 2011 age matched women with previous normotensive pregnancy. All women in this study were retrospectively recruited from the Nord-Trøndelag Health Study (HUNT2). Information from HUNT2 was linked to the Medical Birth Registry of Norway to identify women with a history of preeclampsia and women without a history of preeclampsia. RESULTS: No significant association was found between hypertension (blood pressure ≥140/90 mmHg and/or taking antihypertensive drugs) and the polymorphism in crude analysis (OR (95% CI): CG genotype: 1.07 (0.90-1.27); GG genotype: 1.23 (0.90-1.67)). However, in a minimally adjusted model (age and BMI adjusted), a significant association between the GG genotype and hypertension was found (OR (95% CI): 1.49 (1.05-2.11)). This association remained significant also after adjustment for a history of preeclampsia (OR (95% CI): 1.46 (1.02-2.09)), but not in a model adjusted for multiple other variables (OR (95% CI): 1.26 (0.82-1.94)). In multivariate, but not in crude, analysis, the GG genotype of rs4606 (OR (95% CI): 1.93 (1.05-3.53)) was significantly and independently associated with severe hypertension later in life, defined as systolic blood pressure ≥160 mmHg (stage 2 hypertension) and/or taking antihypertensive drugs. A significant association was also found for the merged CG and GG genotypes (OR (95% CI): 1.43 (1.02-2.00)). Moreover, an interaction with physical activity was found. A history of preeclampsia was a significant and independent predictor of either definition of hypertension, both in crude and adjusted analyses. CONCLUSION: Women carrying the rs4606 CG or GG genotype are at elevated risk for developing hypertension after delivery. Physical activity may interact with the association. Preeclampsia remains an independent risk factor for subsequent hypertension after adjusting for this polymorphism and classical CVD risk factors. BioMed Central 2014-03-05 /pmc/articles/PMC3973870/ /pubmed/24593135 http://dx.doi.org/10.1186/1471-2350-15-28 Text en Copyright © 2014 Kvehaugen et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kvehaugen, Anne Stine
Melien, Øyvind
Holmen, Oddgeir L
Laivuori, Hannele
Dechend, Ralf
Staff, Anne Cathrine
Hypertension after preeclampsia and relation to the C1114G polymorphism (rs4606) in RGS2: data from the Norwegian HUNT2 study
title Hypertension after preeclampsia and relation to the C1114G polymorphism (rs4606) in RGS2: data from the Norwegian HUNT2 study
title_full Hypertension after preeclampsia and relation to the C1114G polymorphism (rs4606) in RGS2: data from the Norwegian HUNT2 study
title_fullStr Hypertension after preeclampsia and relation to the C1114G polymorphism (rs4606) in RGS2: data from the Norwegian HUNT2 study
title_full_unstemmed Hypertension after preeclampsia and relation to the C1114G polymorphism (rs4606) in RGS2: data from the Norwegian HUNT2 study
title_short Hypertension after preeclampsia and relation to the C1114G polymorphism (rs4606) in RGS2: data from the Norwegian HUNT2 study
title_sort hypertension after preeclampsia and relation to the c1114g polymorphism (rs4606) in rgs2: data from the norwegian hunt2 study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973870/
https://www.ncbi.nlm.nih.gov/pubmed/24593135
http://dx.doi.org/10.1186/1471-2350-15-28
work_keys_str_mv AT kvehaugenannestine hypertensionafterpreeclampsiaandrelationtothec1114gpolymorphismrs4606inrgs2datafromthenorwegianhunt2study
AT melienøyvind hypertensionafterpreeclampsiaandrelationtothec1114gpolymorphismrs4606inrgs2datafromthenorwegianhunt2study
AT holmenoddgeirl hypertensionafterpreeclampsiaandrelationtothec1114gpolymorphismrs4606inrgs2datafromthenorwegianhunt2study
AT laivuorihannele hypertensionafterpreeclampsiaandrelationtothec1114gpolymorphismrs4606inrgs2datafromthenorwegianhunt2study
AT dechendralf hypertensionafterpreeclampsiaandrelationtothec1114gpolymorphismrs4606inrgs2datafromthenorwegianhunt2study
AT staffannecathrine hypertensionafterpreeclampsiaandrelationtothec1114gpolymorphismrs4606inrgs2datafromthenorwegianhunt2study